findmyKOL
Clinical trialNCT04093167RecruitingPhase 2/PHASE3Interventional

Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer

SponsorCanadian Cancer Trials GroupEnrollment230Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Cross Cancer Institute

    Edmonton, Alberta, Canada

    Recruiting
  • Bcca - Vancouver

    Vancouver, British Columbia, Canada

    Recruiting
  • Health Sciences North

    Greater Sudbury, Ontario, Canada

    Recruiting
  • Juravinski Cancer Centre at Hamilton Health Sciences

    Hamilton, Ontario, Canada

    Recruiting
  • Kingston Health Sciences Centre

    Kingston, Ontario, Canada

    Recruiting
  • Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada

    Recruiting
  • Algoma District Cancer Program

    Sault Ste. Marie, Ontario, Canada

    Recruiting
  • University Health Network

    Toronto, Ontario, Canada

    Recruiting
  • the Jewish General Hospital

    Montreal, Quebec, Canada

    Recruiting
United States
  • the University of Chicago Medical Center

    Chicago, Illinois, United States

    Recruiting
  • the Sidney Kimmel Comprehensive Cancer Centre

    Baltimore, Maryland, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 May 2020
Primary completion
31 Dec 2026
Completion
30 Jul 2027
Last update posted
9 Jun 2026
Registered enrollment
230
Registry id
NCT04093167

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.